Olé: Towards a PM20D1-based treatment of AD
© 2026 EPFL
Together with former postdoc Jose Sanchez-Mut from the Alicante Neuroscience Institute, Liliane and Johannes showed how PM20D1-derived N-oleoyl-Leucine (OLE) improves AD pathologies in two animal models of Alzheimer's disease.
The study was published in Cell Differentiation and Disease.